Form 8-K - Current report:
SEC Accession No. 0001607062-24-000126
Filing Date
2024-04-18
Accepted
2024-04-18 14:18:21
Documents
14
Period of Report
2024-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybleu041724form8k.htm   iXBRL 8-K 32525
2 EXHIBIT 2.1 ex2_1.htm EX-2.1 240858
  Complete submission text file 0001607062-24-000126.txt   490319

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sybleu-20240415.xsd EX-101.SCH 3215
4 XBRL LABEL FILE sybleu-20240415_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE sybleu-20240415_pre.xml EX-101.PRE 22349
17 EXTRACTED XBRL INSTANCE DOCUMENT sybleu041724form8k_htm.xml XML 3540
Mailing Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465
Business Address 1034 THROGGS NECK EXPRESSWAY BRONX NY 10465 718-795-7790
SYBLEU Inc (Filer) CIK: 0001818674 (see all company filings)

EIN.: 851412307 | State of Incorp.: WY | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-248059 | Film No.: 24853911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)